Tissue and plasma globotriaosylsphingosine could be a biomarker for assessing enzyme replacement therapy for Fabry disease |
| |
Authors: | Tadayasu Togawa Ikuo Kawashima Takashi Kodama Toshihiro Suzuki Takuro Kanekura |
| |
Affiliation: | a Department of Analytical Biochemistry, Meiji Pharmaceutical University, Tokyo, Japan b Department of Clinical Genetics, Meiji Pharmaceutical University, Tokyo, Japan c Department of Molecular Medical Research, The Tokyo Metropolitan Institute of Medical Science, Tokyo Metropolitan Organization for Medical Research, Tokyo, Japan d Department of Dermatology, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, Japan |
| |
Abstract: | Fabry disease is a genetic disease caused by a deficiency of α-galactosidase A (GLA), which leads to systemic accumulation of glycolipids, predominantly globotriaosylceramide (Gb3). With the introduction and spread of enzyme replacement therapy (ERT) with recombinant GLAs for this disease, a useful biomarker for assessing the response to ERT is strongly required. We measured the tissue level of lyso-globotriaosylsphingosine (lyso-Gb3) in Fabry mice by means of high performance liquid chromatography, and compared it with the Gb3 level. The results revealed a marked increase in the lyso-Gb3 level in most tissues of Fabry mice, and which decreased after the administration of a recombinant GLA as in the case of Gb3, which is usually used as a biomarker of Fabry disease. The response was more impressive for lyso-Gb3 compared with for Gb3, especially in kidney tissues, in which a defect significantly influences the morbidity and mortality in patients with this disease. The plasma level of lyso-Gb3 also decreased after the injection of the enzyme, and it was well related to the degradation of tissue lyso-Gb3. Thus, lyso-Gb3 is expected to be a useful new biomarker for assessing the response to ERT for Fabry disease. |
| |
Keywords: | Fabry disease Globotriaosylsphingosine Globotriaosylceramide α-Galactosidase A Enzyme replacement therapy Biomarker |
本文献已被 ScienceDirect 等数据库收录! |
|